Researchers rename PCOS to polyendocrine metabolic ovarian syndrome during Women’s Health Month

LAS VEGAS (KSNV) — During Women’s Health Month, researchers are drawing new attention to a common condition affecting one in eight women by giving it a new name aimed at better reflecting what it is — and how it should be treated.

Polycystic ovary syndrome, long known as PCOS, is now being recognized as polyendocrine metabolic ovarian syndrome, or PMOS. The condition impacts one in eight women, or more than 170 million women worldwide.

The updated name is intended to correct a widespread misunderstanding about the disorder. The previous terminology suggested the root cause was ovarian cysts, but the condition is actually a metabolic and endocrine disorder.

Supporters of the change say the new name could help patients get more targeted care by shifting the focus toward endocrine and metabolic health, rather than centering the condition on the ovaries alone.

PMOS is characterized by fluctuations in hormones that can affect weight, metabolic and mental health, the reproductive system and the skin.

Women experiencing symptoms — or those who previously had trouble getting a diagnosis — are encouraged to revisit the topic with a health care professional.

Survey and global health estimates suggest delays and missed diagnoses are common. A recent Mira survey found that one in four women waited more than five years to receive a PCOS diagnosis, and three in five saw two or more doctors before getting answers. Nearly two-thirds initially assumed their symptoms were just PMS. The World Health Organization estimates that 70% of people with this condition are currently undiagnosed.